The Emerging Genetic Architecture of Type 2 Diabetes

Cell Metabolism

Volumn 8, Issue 3, 2008, Pages 186-200

  Doria, Alessandro ^a   Patti, Mary Elizabeth ^a   Kahn, C Ronald ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; GLUCOKINASE; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HOMEODOMAIN PROTEIN; INITIATION FACTOR 2ALPHA; INSULIN; INSULIN RECEPTOR; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; KINESIN; KRUPPEL LIKE FACTOR; LAMIN A; LAMIN B; LAMIN C; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN; NEUROGENIC DIFFERENTIATION FACTOR; NOTCH2 RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE (CALCIUM,CALMODULIN); SOMATOMEDIN BINDING PROTEIN 2; SULFONYLUREA RECEPTOR; TRANSCRIPTION FACTOR 7 LIKE 2; TRANSCRIPTION FACTOR PDX 1; ZINC FINGER PROTEIN;

ENVIRONMENTAL FACTOR; FAMILY STUDY; GENE ACTIVITY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GLUCOSE HOMEOSTASIS; HEREDITY; HUMAN; LINKAGE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HOMEOSTASIS; HUMANS; QUANTITATIVE TRAIT LOCI; RISK FACTORS;

EID: 50049086521     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2008.08.006     Document Type: Review

References (120)

1. Almind K., Inoue G., Pedersen O., and Kahn C.R. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. J. Clin. Invest. 97 (1996) 2569-2575
2. Almind K., Delahaye L., Hansen T., Van Obberghen E., Pedersen O., and Kahn C.R. Characterization of the Met326Ile variant of phosphatidylinositol 3-kinase p85alpha. Proc. Natl. Acad. Sci. USA 99 (2002) 2124-2128
3. Almind K., Kulkarni R.N., Lannon S.M., and Kahn C.R. Identification of Interactive Loci Linked to Insulin and Leptin in Mice With Genetic Insulin Resistance. Diabetes 52 (2003) 1535-1543
4. Altshuler D., Hirschhorn J.N., Klannemark M., Lindgren C.M., Vohl M.C., Nemesh J., Lane C.R., Schaffner S.F., Bolk S., Brewer C., et al. The common PPARgamma Pro12Ala is associated with decreased risk of type 2 diabetes. Nat. Genet. 26 (2000) 76-80
5. Barroso I., Gurnell M., Crowley V.E., Agostini M., Schwabe J.W., Soos M.A., Maslen G.L., Williams T.D., Lewis H., Schafer A.J., et al. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402 (1999) 880-883
6. Barroso I., Luan J., Middelberg R.P., Harding A.H., Franks P.W., Jakes R.W., Clayton D., Schafer A.J., O'Rahilly S., and Wareham N.J. Candidate Gene Association Study in Type 2 Diabetes Indicates a Role for Genes Involved in beta-Cell Function as Well as Insulin Action. PLoS Biol. 1 (2003) E20
7. Beamer B.A., Yen C.J., Andersen R.E., Muller D., Elahi D., Cheskin L.J., Andres R., Roth J., and Shuldiner A.R. Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor γ2 gene with obesity in two Caucasian populations. Diabetes 47 (1998) 1806-1808
8. Bergman R.N. Orchestration of glucose homeostasis: from a small acorn to the California oak. Diabetes 56 (2007) 1489-1501
9. Birney E., Stamatoyannopoulos J.A., Dutta A., Guigo R., Gingeras T.R., Margulies E.H., Weng Z., Snyder M., Dermitzakis E.T., Thurman R.E., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447 (2007) 799-816
10. Brunham L.R., Singaraja R.R., and Hayden M.R. Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis. Annu. Rev. Nutr. 26 (2006) 105-129
11. Bruning J.C., Winnay J., Bonner-Weir S., Taylor S.I., Accili D., and Kahn C.R. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88 (1997) 561-572
12. Carroll J.S., Liu X.S., Brodsky A.S., Li W., Meyer C.A., Szary A.J., Eeckhoute J., Shao W., Hestermann E.V., Geistlinger T.R., et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122 (2005) 33-43
13. Cauchi S., Meyre D., Dina C., Choquet H., Samson C., Gallina S., Balkau B., Charpentier G., Pattou F., Stetsyuk V., et al. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 55 (2006) 2903-2908
14. Cauchi S., Choquet H., Gutierrez-Aguilar R., Capel F., Grau K., Proenca C., Dina C., Duval A., Balkau B., Marre M., et al. Effects of TCF7L2 polymorphisms on obesity in European populations. Obesity (Silver Spring) 16 (2008) 476-482
15. Cauchi S., Meyre D., Durand E., Proenca C., Marre M., Hadjadj S., Choquet H., De Graeve F., Gaget S., Allegaert F., et al. Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS ONE 3 (2008) e2031
16. Chambers J.C., Elliott P., Zabaneh D., Zhang W., Li Y., Froguel P., Balding D., Scott J., and Kooner J.S. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat. Genet. 40 (2008) 716-718
17. Chen W.M., Erdos M.R., Jackson A.U., Saxena R., Sanna S., Silver K.D., Timpson N.J., Hansen T., Orru M., Grazia P.M., et al. Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J. Clin. Invest. 118 (2008) 2620-2628
18. Chimienti F., Devergnas S., Favier A., and Seve M. Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 53 (2004) 2330-2337
19. Chimienti F., Devergnas S., Pattou F., Schuit F., Garcia-Cuenca R., Vandewalle B., Kerr-Conte J., Van Lommel L., Grunwald D., Favier A., and Seve M. In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J. Cell Sci. 119 (2006) 4199-4206
20. Cossu G., and Borello U. Wnt signaling and the activation of myogenesis in mammals. EMBO J. 18 (1999) 6867-6872
21. Cowie C.C., Rust K.F., Byrd-Holt D.D., Eberhardt M.S., Flegal K.M., Engelgau M.M., Saydah S.H., Williams D.E., Geiss L.S., and Gregg E.W. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 29 (2006) 1263-1268
22. Crunkhorn S., Dearie F., Mantzoros C., Gami H., da Silva W.S., Espinoza D., Faucette R., Barry K., Bianco A.C., and Patti M.E. Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. J. Biol. Chem. 282 (2007) 15439-15450
23. Deeb S.S., Fajas L., Nemoto M., Pihlajamäki J., Mykkänen L., Kuusisto J., Laakso M., Fujimoto W., and Auwerx J. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 20 (1998) 284-287
24. Dina C., Meyre D., Gallina S., Durand E., Korner A., Jacobson P., Carlsson L.M., Kiess W., Vatin V., Lecoeur C., et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat. Genet. 39 (2007) 724-726
25. Duncan S.A., Navas M.A., Dufort D., Rossant J., and Stoffel M. Regulation of a transcription factor network required for differentiation and metabolism. Science 281 (1998) 692-695
26. Farris W., Mansourian S., Chang Y., Lindsley L., Eckman E.A., Frosch M.P., Eckman C.B., Tanzi R.E., Selkoe D.J., and Guenette S. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta -protein, and the beta -amyloid precursor protein intracellular domain in vivo. Proc. Natl. Acad. Sci. USA 100 (2003) 4162-4167
27. Fehmann H.C., Goke R., and Goke B. Cell and molecular biology of the incretin hormones glucagon-like peptide I and glucose-dependent insulin releasing polypeptide. Endocr. Rev. 16 (1995) 390-410
28. Feuk L., Carson A.R., and Scherer S.W. Structural variation in the human genome. Nat. Rev. Genet. 7 (2006) 85-97
29. Flegal K.M., Ezzati T.M., Harris M.I., Haynes S.G., Juarez R.Z., Knowler W.C., Perez-Stable E.J., and Stern M.P. Prevalence of diabetes in Mexican-Americans, Cubans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey 1982-1984. Diabetes Care 14 (1991) 628-638
30. Florez J.C., Sjogren M., Burtt N., Orho-Melander M., Schayer S., Sun M., Almgren P., Lindblad U., Tuomi T., Gaudet D., et al. Association testing in 9,000 people fails to confirm the association of the insulin receptor substrate-1 G972R polymorphism with type 2 diabetes. Diabetes 53 (2004) 3313-3318
31. Florez J.C., Burtt N., de Bakker P.I., Almgren P., Tuomi T., Holmkvist J., Gaudet D., Hudson T.J., Schaffner S.F., Daly M.J., et al. Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. Diabetes 53 (2004) 1360-1368
32. Florez J.C., Jablonski K.A., Bayley N., Pollin T.I., de Bakker P.I., Shuldiner A.R., Knowler W.C., Nathan D.M., and Altshuler D. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N. Engl. J. Med. 355 (2006) 241-250
33. Florez J.C., Wiltshire S., Agapakis C.M., Burtt N.P., de Bakker P.I., Almgren P., Bengtsson B.K., Tuomi T., Gaudet D., Daly M.J., et al. High-density haplotype structure and association testing of the insulin-degrading enzyme (IDE) gene with type 2 diabetes in 4,206 people. Diabetes 55 (2006) 128-135
34. Florez J.C., Manning A.K., Dupuis J., McAteer J., Irenze K., Gianniny L., Mirel D.B., Fox C.S., Cupples L.A., and Meigs J.B. A 100K genome-wide association scan for diabetes and related traits in the Framingham Heart Study: replication and integration with other genome-wide datasets. Diabetes 56 (2007) 3063-3074
35. Foley A.C., and Mercola M. Heart induction by Wnt antagonists depends on the homeodomain transcription factor Hex. Genes Dev. 19 (2005) 387-396
36. Frayling T.M., Timpson N.J., Weedon M.N., Zeggini E., Freathy R.M., Lindgren C.M., Perry J.R., Elliott K.S., Lango H., Rayner N.W., et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316 (2007) 889-894
37. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., Belmont J.W., Boudreau A., Hardenbol P., Leal S.M., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449 (2007) 851-861
38. Gerken T., Girard C.A., Tung Y.C., Webby C.J., Saudek V., Hewitson K.S., Yeo G.S., McDonough M.A., Cunliffe S., McNeill L.A., et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318 (2007) 1469-1472
39. Gloyn A.L., Pearson E.R., Antcliff J.F., Proks P., Bruining G.J., Slingerland A.S., Howard N., Srinivasan S., Silva J.M., Molnes J., et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N. Engl. J. Med. 350 (2004) 1838-1849
40. Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., Helgason A., Stefansson H., Emilsson V., Helgadottir A., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38 (2006) 320-323
41. Grarup N., Andersen G., Krarup N.T., Albrechtsen A., Schmitz O., Jorgensen T., Borch-Johnsen K., Hansen T., and Pedersen O. Association testing of novel type 2 diabetes risk-alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity and obesity in a population-based sample of 4,516 glucose-tolerant middle-aged Danes. Diabetes (2008) in press
42. Gunton J.E., Kulkarni R.N., Yim S., Okada T., Hawthorne W.J., Tseng Y.H., Roberson R.S., Ricordi C., O'Connell P.J., Gonzalez F.J., and Kahn C.R. Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 122 (2005) 337-349
43. Hansen L., and Pedersen O. Genetics of type 2 diabetes mellitus: status and perspectives. Diabetes Obes. Metab. 7 (2005) 122-135
44. Hanson R.L., Bogardus C., Duggan D., Kobes S., Knowlton M., Infante A.M., Marovich L., Benitez D., Baier L.J., and Knowler W.C. A search for variants associated with young-onset type 2 diabetes in American Indians in a 100K genotyping array. Diabetes 56 (2007) 3045-3052
45. Hayes M.G., Pluzhnikov A., Miyake K., Sun Y., Ng M.C., Roe C.A., Below J.E., Nicolae R.I., Konkashbaev A., Bell G.I., et al. Identification of type 2 diabetes genes in Mexican Americans through genome-wide association studies. Diabetes 56 (2007) 3033-3044
46. Helgadottir A., Thorleifsson G., Manolescu A., Gretarsdottir S., Blondal T., Jonasdottir A., Jonasdottir A., Sigurdsson A., Baker A., Palsson A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316 (2007) 1491-1493
47. Helgadottir A., Thorleifsson G., Magnusson K.P., Gretarsdottir S., Steinthorsdottir V., Manolescu A., Jones G.T., Rinkel G.J., Blankensteijn J.D., Ronkainen A., et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat. Genet. 40 (2008) 217-224
48. Hogan P., Dall T., and Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 26 (2003) 917-932
49. Jimenez-Chillaron J.C., Hernandez-Valencia M., Lightner A., Faucette R.R., Reamer C., Przybyla R., Ruest S., Barry K., Otis J.P., and Patti M.E. Reductions in caloric intake and early postnatal growth prevent glucose intolerance and obesity associated with low birthweight. Diabetologia 49 (2006) 1974-1984
50. Kahn C.R. Insulin action, diabetogenes, and the cause of type II diabetes (Banting Lecture). Diabetes 43 (1994) 1066-1084
51. Kahn C.R., Vicent D., and Doria A. Genetics of non-insulin-dependent (type-II) diabetes mellitus. Annu. Rev. Med. 47 (1996) 509-531
52. Kamb A., Gruis N.A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S.V., Stockert E., Day III R.S., Johnson B.E., and Skolnick M.H. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264 (1994) 436-440
53. Kapitein L.C., Peterman E.J., Kwok B.H., Kim J.H., Kapoor T.M., and Schmidt C.F. The bipolar mitotic kinesin Eg5 moves on both microtubules that it crosslinks. Nature 435 (2005) 114-118
54. Kissebah A.H., Sonnenberg G.E., Myklebust J., Goldstein M., Broman K., James R.G., Marks J.A., Krakower G.R., Jacob H.J., Weber J., et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc. Natl. Acad. Sci. USA 97 (2000) 14478-14483
55. Krolewski A.S., and Warram J.H. Epidemiology of late complications of diabetes: A basis for the development and evaluation of preventive program. In: Kahn C.R., Weir G.C., King G.L., Moses A.C., Smith R.J., and Jacobson A.M. (Eds). Joslin's Diabetes Mellitus (2005), Lippincott, Williams & Wilkins, New York
56. Ling C., Poulsen P., Carlsson E., Ridderstrale M., Almgren P., Wojtaszewski J., Beck-Nielsen H., Groop L., and Vaag A. Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins. J. Clin. Invest. 114 (2004) 1518-1526
57. Ling C., Poulsen P., Simonsson S., Ronn T., Holmkvist J., Almgren P., Hagert P., Nilsson E., Mabey A.G., Nilsson P., et al. Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle. J. Clin. Invest. 117 (2007) 3427-3435
58. Loos R.J., Lindgren C.M., Li S., Wheeler E., Zhao J.H., Prokopenko I., Inouye M., Freathy R.M., Attwood A.P., Beckmann J.S., et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat. Genet. 40 (2008) 768-775
59. Lyssenko V., Almgren P., Anevski D., Perfekt R., Lahti K., Nissen M., Isomaa B., Forsen B., Homstrom N., Saloranta C., et al. Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 54 (2005) 166-174
60. Lyssenko V., Lupi R., Marchetti P., Del Guerra S., Ortho-Melander M., Almgren P., Sjogren M., Ling C., Eriksson K.F., Lethagen A.-L., et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J. Clin. Invest. 117 (2007) 2155-2163
61. Magre J., Delepine M., Khallouf E., Gedde-Dahl Jr. T., Van Maldergem L., Sobel E., Papp J., Meier M., Megarbane A., Bachy A., et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat. Genet. 28 (2001) 365-370
62. Martin B.C., Warram J.H., Krolewski A.S., Bergman R.N., Soeldner J.S., and Kahn C.R. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340 (1992) 925-929
63. McAteer J.B., Prudente S., Bacci S., Lyon H.N., Hirschhorn J.N., Trischitta V., and Florez J.C. The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: evidence from an updated meta-analysis in 42,042 subjects. Diabetes 57 (2008) 1125-1130
64. McLin V.A., Rankin S.A., and Zorn A.M. Repression of Wnt/beta-catenin signaling in the anterior endoderm is essential for liver and pancreas development. Development 134 (2007) 2207-2217
65. McPherson R., Pertsemlidis A., Kavaslar N., Stewart A., Roberts R., Cox D.R., Hinds D.A., Pennacchio L.A., Tybjaerg-Hansen A., Folsom A.R., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316 (2007) 1488-1491
66. Moore A.F., Jablonski K.A., McAteer J.B., Saxena R., Pollin T.I., Franks P.W., Hanson R.L., Shuldiner A.R., Knowler W.C., Altshuler D., and Florez J.C. Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program. Diabetes (2008) in press
67. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstrale M., Laurila E., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34 (2003) 267-273
68. Nielsen J., Christiansen J., Lykke-Andersen J., Johnsen A.H., Wewer U.M., and Nielsen F.C. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol. Cell. Biol. 19 (1999) 1262-1270
69. Nielsen E.M., Hansen L., Carstensen B., Echwald S.M., Drivsholm T., Glumer C., Thorsteinsson B., Borch-Johnsen K., Hansen T., and Pedersen O. The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 52 (2003) 573-577
70. Nobori T., Takabayashi K., Tran P., Orvis L., Batova A., Yu A.L., and Carson D.A. Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers. Proc. Natl. Acad. Sci. USA 93 (1996) 6203-6208
71. O'Rahilly S. Human obesity and insulin resistance: lessons from experiments of nature. Biochem. Soc. Trans. 35 (2007) 33-36
72. Ozanne S.E., and Constancia M. Mechanisms of disease: the developmental origins of disease and the role of the epigenotype. Nat. Clin. Pract. Endocrinol. Metab. 3 (2007) 539-546
73. Palmer N.D., Goodarzi M.O., Langefeld C.D., Ziegler J., Norris J.M., Haffner S.M., Bryer-Ash M., Bergman R.N., Wagenknecht L.E., Taylor K.D., et al. Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study. Diabetes 57 (2008) 1093-1100
74. Park J.H., Stoffers D.A., Nicholls R.D., and Simmons R.A. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J. Clin. Invest. 118 (2008) 2316-2324
75. Parton L.E., Ye C.P., Coppari R., Enriori P.J., Choi B., Zhang C.Y., Xu C., Vianna C.R., Balthasar N., Lee C.E., et al. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 449 (2007) 228-232
76. Pascoe L., Tura A., Patel S.K., Ibrahim I.M., Ferrannini E., Zeggini E., Weedon M.N., Mari A., Hattersley A.T., McCarthy M.I., et al. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Diabetes 56 (2007) 3101-3104
77. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. USA 100 (2003) 8466-8471
78. Pearson E.R., Flechtner I., Njolstad P.R., Malecki M.T., Flanagan S.E., Larkin B., Ashcroft F.M., Klimes I., Codner E., Iotova V., et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N. Engl. J. Med. 355 (2006) 467-477
79. Pizzuti A., Frittitta L., Argiolas A., Baratta R., Goldfine I.D., Bozzali M., Ercolino T., Scarlato G., Iacoviello L., Vigneri R., et al. A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes 48 (1999) 1881-1884
80. Pomerantz J., Schreiber-Agus N., Liegeois N.J., Silverman A., Alland L., Chin L., Potes J., Chen K., Orlow I., Lee H.W., et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2′s inhibition of p53. Cell 92 (1998) 713-723
81. Pospisilik J.A., Knauf C., Joza N., Benit P., Orthofer M., Cani P.D., Ebersberger I., Nakashima T., Sarao R., Neely G., et al. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 131 (2007) 476-491
82. Poulsen P., Kyvik K.O., Vaag A., and Beck-Nielsen H. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance-a population-based twin study. Diabetologia 42 (1999) 139-145
83. Prestwich T.C., and MacDougald O.A. Wnt/beta-catenin signaling in adipogenesis and metabolism. Curr. Opin. Cell Biol. 19 (2007) 612-617
84. Pritchard J.K., and Cox N.J. The allelic architecture of human disease genes: common disease-common variant...or not?. Hum. Mol. Genet. 11 (2002) 2417-2423
85. Prunier C., Hocevar B.A., and Howe P.H. Wnt signaling: physiology and pathology. Growth Factors 22 (2004) 141-150
86. Qiu W.Q., Walsh D.M., Ye Z., Vekrellis K., Zhang J., Podlisny M.B., Rosner M.R., Safavi A., Hersh L.B., and Selkoe D.J. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J. Biol. Chem. 273 (1998) 32730-32738
87. Rampersaud E., Damcott C.M., Fu M., Shen H., McArdle P., Shi X., Shelton J., Yin J., Chang Y.P., Ott S.H., et al. Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: evidence for replication from diabetes-related quantitative traits and from independent populations. Diabetes 56 (2007) 3053-3062
88. Rane S.G., Dubus P., Mettus R.V., Galbreath E.J., Boden G., Reddy E.P., and Barbacid M. Loss of cyclin-dependent kinase (Cdk4) expression causes insulin-deficient diabetes and cdk4 activation results in β-islet cell hyperplasia. Nat. Genet. 22 (1999) 44-52
89. Raychaudhuri N., Raychaudhuri S., Thamotharan M., and Devaskar S.U. Histone code modifications repress glucose transporter 4 expression in the intrauterine growth-restricted offspring. J. Biol. Chem. 283 (2008) 13611-13626
90. Raz I., Karsai D., and Katz M. The influence of zinc supplementation on glucose homeostasis in NIDDM. Diabetes Res. 11 (1989) 73-79
91. Reich D.E., and Lander E.S. On the allelic spectrum of human disease. Trends Genet. 17 (2001) 502-510
92. Rich S.S. Mapping genes in diabetes: Genetic epidemiological perspective. Diabetes 39 (1990) 1315-1319
93. Ronn T., Poulsen P., Hansson O., Holmkvist J., Almgren P., Nilsson P., Tuomi T., Isomaa B., Groop L., Vaag A., and Ling C. Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle. Diabetologia 51 (2008) 1159-1168
94. Salonen J.T., Uimari P., Aalto J.M., Pirskanen M., Kaikkonen J., Todorova B., Hypponen J., Korhonen V.P., Asikainen J., Devine C., et al. Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium. Am. J. Hum. Genet. 81 (2007) 338-345
95. Saxena R., Voight B.F., Lyssenko V., Burtt N.P., de Bakker P.I., Chen H., Roix J.J., Kathiresan S., Hirschhorn J.N., Daly M.J., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316 (2007) 1331-1336
96. Schwanstecher C., Meyer U., and Schwanstecher M. K(IR)6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP-sensitive K(+) channels. Diabetes 51 (2002) 875-879
97. Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., Erdos M.R., Stringham H.M., Chines P.S., Jackson A.U., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316 (2007) 1341-1345
98. Shackleton S., Lloyd D.J., Jackson S.N., Evans R., Niermeijer M.F., Singh B.M., Schmidt H., Brabant G., Kumar S., Durrington P.N., et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat. Genet. 24 (2000) 153-156
99. Sharif J., Nakamura M., Ito T., Kimura Y., Nagamune T., Mitsuya K., and Okamura K. Food restriction in pregnant mice can induce changes in histone modifications and suppress gene expression in fetus. Nucleic Acids Symp Ser (Oxf) 51 (2007) 125-126
100. Shu L., Sauter N.S., Schulthess F.T., Matveyenko A.V., Oberholzer J., and Maedler K. TCF7L2 regulates -cell survival and function in human pancreatic islets. Diabetes 57 (2008) 645-653
101. Simon S.F., and Taylor C.G. Dietary zinc supplementation attenuates hyperglycemia in db/db mice. Exp. Biol. Med. (Maywood) 226 (2001) 43-51
102. Skyler J.S., and Oddo C. Diabetes trends in the USA. Diabetes Metab. Res. Rev. 18 Suppl 3 (2002) S21-S26
103. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., Boutin P., Vincent D., Belisle A., Hadjadj S., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445 (2007) 881-885
104. Stancáková A., Pihlajamaki J., Kuusisto J., Stefan N., Fritsche A., Haring H., Andreozzi F., Succurro E., Sesti G., Boesgaard T.W., et al. Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance. J. Clin. Endocrinol. Metab. 93 (2008) 1924-1930
105. Steinthorsdottir V., Thorleifsson G., Reynisdottir I., Benediktsson R., Jonsdottir T., Walters G.B., Styrkarsdottir U., Gretarsdottir S., Emilsson V., Ghosh S., et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat. Genet. 39 (2007) 770-775
106. Stern M.P. Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 44 (1995) 369-374
107. Stern M.P. The search for type 2 diabetes susceptibility genes using whole-genome scans: an epidemiologist's perspective. Diabetes Metab. Res. Rev. 18 (2002) 106-113
108. Strachan T., and Read A. Human Molecular Genetics (2003), Garland Science, Oxford
109. Tanaka T., Inazu T., Yamada K., Myint Z., Keng V.W., Inoue Y., Taniguchi N., and Noguchi T. cDNA cloning and expression of rat homeobox gene, Hex, and functional characterization of the protein. Biochem. J. 339 (1999) 111-117
110. Taylor C.G. Zinc, the pancreas, and diabetes: insights from rodent studies and future directions. Biometals 18 (2005) 305-312
111. Ubeda M., Rukstalis J.M., and Habener J.F. Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity. J. Biol. Chem. 281 (2006) 28858-28864
112. Vavouri T., McEwen G.K., Woolfe A., Gilks W.R., and Elgar G. Defining a genomic radius for long-range enhancer action: duplicated conserved non-coding elements hold the key. Trends Genet. 22 (2006) 5-10
113. Vionnet N., El Habib H., Dupont S., Gallina S., Francke S., Dotte S., De Matos F., Durand E., Lepretre F., Lecoeur C., et al. Genomewide search for type 2 diabetes-susceptibility genes in french whites: evidence for a novel susceptibility locus for early-onset diabetes on chrososome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am. J. Hum. Genet. 67 (2000) 1470-1480
114. Watanabe R.M., Allayee H., Xiang A.H., Trigo E., Hartiala J., Lawrence J.M., and Buchanan T.A. Transcription factor 7-like 2 (TCF7L2) is associated with gestational diabetes mellitus and interacts with adiposity to alter insulin secretion in Mexican Americans. Diabetes 56 (2007) 1481-1485
115. Weijnen C.F., Rich S.S., Meigs J.B., Krolewski A.S., and Warram J.H. Risk of diabetes in siblings of index cases with Type 2 diabetes: implications for genetic studies. Diabet. Med. 19 (2002) 41-50
116. Wenzlau J.M., Juhl K., Yu L., Moua O., Sarkar S.A., Gottlieb P., Rewers M., Eisenbarth G.S., Jensen J., Davidson H.W., and Hutton J.C. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc. Natl. Acad. Sci. USA 104 (2007) 17040-17045
117. Woo M., and Patti M.E. Diabetes risk begins in utero. Cell Metab. 8 (2008) 5-7
118. Yi F., Brubaker P.L., and Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J. Biol. Chem. 280 (2005) 1457-1464
119. Zeggini E., Weedon M.N., Lindgren C.M., Frayling T.M., Elliott K.S., Lango H., Timpson N.J., Perry J.R., Rayner N.W., Freathy R.M., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316 (2007) 1336-1341
120. Zeggini E., Scott L.J., Saxena R., Voight B.F., Marchini J.L., Hu T., de Bakker P.I., Abecasis G.R., Almgren P., Andersen G., et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet. 40 (2008) 638-645